Table I.
Patient characteristics of 129 patients with non-small cell lung cancer.
| Variable | Value |
|---|---|
| Gender, n (%) | |
| Male | 96 (74.4) |
| Female | 33 (25.6) |
| Age, years | |
| Mean | 61.2 |
| Range | 20–80 |
| Smoking status, n (%) | |
| No | 50 (38.8) |
| Yes | 79 (61.2) |
| Histological status, n (%)a | |
| AC | 54 (41.9) |
| SCC | 52 (40.3) |
| ASC | 15 (11.6) |
| Other | 8 (6.2) |
| EGFR mutation, n (%) | |
| No | 115 (89.1) |
| Yes | 14 (10.9) |
| Stage, n (%)b | |
| I | 23 (17.9) |
| II | 27 (20.9) |
| III | 63 (48.8) |
| IV | 16 (12.4) |
| Follow-up status, n (%) | |
| Survival | 46 (35.7) |
| Mortality | 69 (53.5) |
| Lost to follow-up | 14 (10.9) |
a
World Health Organization
b
American Joint Committee on Cancer. AC, adenocarcinoma; SCC, squamous cell carcinoma; ASC, adenosquamous carcinoma; Other, large cell carcinoma and anaplastic carcinoma; EGFR, epidermal growth factor receptor.